Home/Pipeline/Alzheimer's Biomarker

Alzheimer's Biomarker

Alzheimer's Disease Diagnosis

Test StageActive

Key Facts

Indication

Alzheimer's Disease Diagnosis

Phase

Test Stage

Status

Active

Company

Aelan Cell Technologies

About Aelan Cell Technologies

Aelan Cell Technologies is a private, pre-revenue biotech firm developing a novel platform to harness the therapeutic potential of adult stem cells, which it conceptualizes as a 'pharmacy' of natural regenerative factors. Its pipeline includes programs in regenerative medicine for post-cancer treatment recovery, a diagnostic biomarker for Alzheimer's disease, and personalized anti-aging cosmetics. The company is building its intellectual property portfolio and has established key research collaborations with institutions like the Buck Institute and the Gladstone Institute to advance its technologies.

View full company profile

Therapeutic Areas

Oncology Supportive Care Neurodegenerative Disorders Regenerative Medicine

Other Alzheimer's Disease Diagnosis Drugs

Drug	Company	Phase	Status
iRS-AD	BetaSense	Research/Development	Active
Afina Retinal Imaging	NeuroVision Imaging	Validation/Development	Active
Aβ1-40/Aβ1-42/Tau IMR Reagents	MagQu	Commercial	Active
Oligomer Diagnostic Biomarkers	Abyssinia Biologics	Preclinical/Research	Active
ABtest-Service	Araclon Biotech	Commercial	Active
AlzTEST®	Neuron Biopharma	Not Specified	Active